MTOR and neoplasm: Tumour masses from mice injected with UCP2 (genipin) and mTOR inhibitors (everolimus) revealed a strong reduction in tumour volume and number of mitosis, associated with a marked cytosolic glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) nuclear positivity.